Ju‐Hee Bang
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
-
- Chronic Lymphocytic Leukemia Research
Papers in ⓘ
- Oncology 18
- PARP inhibition in cancer therapy 8
- Pancreatic and Hepatic Oncology Research 3
-
- TGF-β signaling in diseases 4
- Co-authors
- Do‐Youn Oh (28 shared papers)Kyung-Hun Lee (7 shared papers)Yung‐Jue Bang (10 shared papers)Tae‐Yong Kim (10 shared papers)Sae‐Won Han (5 shared papers)Seock‐Ah Im (6 shared papers)Tae‐You Kim (5 shared papers)Hyerim Ha (4 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Cancer Research (7 papers)Blood (5 papers)Cell Communication and Signaling (3 papers)Cancer Research and Treatment (2 papers)
- Partner nations
- South KoreaUnited StatesThailand
In The Last Decade
Ju‐Hee Bang
36 papers receiving 381 citations
Peers
Comparison fields: 5 of 54
- Oncology 261
- Genetics 59
- Hematology 60
- Surgery 158
- Pulmonary and Respiratory Medicine 83
Countries citing papers authored by Ju‐Hee Bang
This map shows the geographic impact of Ju‐Hee Bang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju‐Hee Bang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju‐Hee Bang more than expected).
Fields of papers citing papers by Ju‐Hee Bang
This network shows the impact of papers produced by Ju‐Hee Bang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju‐Hee Bang. The network helps show where Ju‐Hee Bang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju‐Hee Bang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 86 | |
| 2 | 2016 | 67 | |
| 3 | 2020 | 60 | |
| 4 | 2020 | 19 | |
| 5 | 2012 | 17 | |
| 6 | The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer. | 2015 | 13 |
| 7 | 2019 | 13 | |
| 8 | 2011 | 12 | |
| 9 | 2022 | 12 | |
| 10 | 2021 | 10 | |
| 11 | 2012 | 10 | |
| 12 | 2013 | 10 | |
| 13 | 2024 | 7 | |
| 14 | 2011 | 6 | |
| 15 | 2016 | 6 | |
| 16 | 2021 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2019 | 3 | |
| 19 | 2012 | 3 | |
| 20 | 2012 | 2 |
About Ju‐Hee Bang
Ju‐Hee Bang is a scholar working on Oncology, Molecular Biology, Surgery, Pathology and Forensic Medicine and Genetics, having authored 39 papers that have together received 385 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), PARP inhibition in cancer therapy (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), TGF-β signaling in diseases (4 papers), Gastric Cancer Management and Outcomes (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Oncology (261 citations), Genetics (59 citations), Hematology (60 citations), Surgery (158 citations) and Pulmonary and Respiratory Medicine (83 citations). Ju‐Hee Bang has collaborated with scholars based in South Korea, United States and Thailand. Frequent co-authors include Do‐Youn Oh, Kyung-Hun Lee, Yung‐Jue Bang, Tae‐Yong Kim, Sae‐Won Han, Seock‐Ah Im, Tae‐You Kim, Hyerim Ha, Ji‐Eun Park and Jin Won Kim. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Blood, Cell Communication and Signaling and Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.